Brief: Cassava Sciences's First Phase 3 Trial Expected To Read Out By December 2024

Filana Therapeutics

22/07/2024 13:31

July 22 (Reuters) - Cassava Sciences Inc  SAVA.O :
    * CASSAVA SCIENCES INC: FIRST PHASE 3 TRIAL IS EXPECTED TO
READ
OUT BY DECEMBER 2024 - SEC FILING
    * CASSAVA SCIENCES INC: SECOND PHASE 3 TRIAL IS EXPECTED TO
CONCLUDE BY JUNE 2025
    * CASSAVA SCIENCES : WILL INFORM CASSAVA COMMUNITY OF
MATERIAL
NEWS ABOUT CO AND CLINICAL TRIALS
    * CASSAVA SCIENCES : BOARD IS 100% COMMITTED TO COMPLETING
PHASE 3
PROGRAM, RELEASING RESULTS ON TIME

Source text for Eikon:  ID:n0001437749-24-023128 
Further company coverage:  SAVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))